We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Abbott Introduces GLP Systems Track Laboratory Automation Solution

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: GLP Systems offers global scale and is trusted by more than 25 sites globally (Photo courtesy of Abbott)
Image: GLP Systems offers global scale and is trusted by more than 25 sites globally (Photo courtesy of Abbott)

Abbott (Lake Forest, IL, USA) is participating in EuroMedLab-WorldLab 2023 where it is introducing GLP Systems, an innovative total laboratory automation (TLA) solution, offering proven technology with more flexibility and options to meet high volume needs.

Clinical labs are constantly on the lookout for solutions that can help them process an increasing number of sample tubes more efficiently, while simultaneously reducing costs and maintenance of their systems. A significant objective is to facilitate connectivity with a diverse range of instruments, which would help reduce both complexity and cost, and most importantly, simplify the decision-making process regarding automation. The GLP TLA system, which employs an automated sample delivery track system, handles an impressive 900 samples per hour end-to-end. This automation significantly cuts down turnaround time, positively impacting patient care, especially in critical care units. The system also includes a feature that limits direct contact with patients' blood samples, thus safeguarding the workers. It enhances efficiency through consistent sample management, thereby ensuring a more reliable and speedier laboratory service.

The GLP TLA system can markedly boost the efficacy of laboratory testing. A standout feature of this system is its multi-floor transport capability, which eliminates the boundaries between various departments and floors, thereby expediting the availability of test results for doctors. The GLP TLA system mitigates the risks associated with implementing a long-term solution, thanks to its innovative track design. Labs now have the flexibility to modify their track to accommodate future changes and can optimize floor space by evolving their labs from a 2D to a 3D setup. The system also alleviates the common difficulties associated with adopting a new automation system by minimizing the time needed for track implementation and offering more efficient service and training. The GLP TLA system allows labs to concentrate on crucial tasks by maximizing uptime with infinite redundancy, streamlining workflow, and reducing turnaround time.

Related Links:
Abbott 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.